Mephenytoin

cytochrome P450 family 4 subfamily F member 3 ; Homo sapiens







24 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 30399481 Investigation on drug-binding in heme pocket of CYP2C19 with UV-visible and resonance Raman spectroscopies. 2019 Feb 15 1
2 22765278 Effect of peginterferon alfa-2a (40KD) on cytochrome P450 isoenzyme activity. 2013 Feb 1
3 21198441 An in vitro, high throughput, seven CYP cocktail inhibition assay for the evaluation of new chemical entities using LC-MS/MS. 2011 Jan 1
4 11956503 Acute hypoxia and cytochrome P450-mediated hepatic drug metabolism in humans. 2002 Apr 1
5 11037108 Characterization of transgenic mouse strains using six human hepatic cytochrome P450 probe substrates. 2000 Aug 2
6 9190854 Reappraisal of human CYP isoforms involved in imipramine N-demethylation and 2-hydroxylation: a study using microsomes obtained from putative extensive and poor metabolizers of S-mephenytoin and eleven recombinant human CYPs. 1997 Jun 3
7 8861658 Investigation of xenobiotic metabolism by CYP2D6 and CYP2C19: importance of enantioselective analytical methods. 1996 Mar 29 1
8 7704038 Lack of low Km diazepam N-demethylase in livers of poor metabolizers for S-mephenytoin 4'-hydroxylation. 1994 Dec 2
9 8454228 [Genetic polymorphism in human drug metabolism]. 1993 Feb 2
10 1441599 Polymorphism in stereoselective hydroxylations of mephenytoin and hexobarbital by Japanese liver samples in relation to cytochrome P-450 human-2 (IIC9). 1992 Sep-Oct 2
11 1857342 Separation of human liver microsomal tolbutamide hydroxylase and (S)-mephenytoin 4'-hydroxylase cytochrome P-450 enzymes. 1991 Jul 1
12 2669966 Expression of a human liver cytochrome P-450 protein with tolbutamide hydroxylase activity in Saccharomyces cerevisiae. 1989 Jun 13 1
13 2910639 Propranolol's metabolism is determined by both mephenytoin and debrisoquin hydroxylase activities. 1989 Jan 1
14 2827463 Human cytochrome P-450 PB-1: a multigene family involved in mephenytoin and steroid oxidations that maps to chromosome 10. 1988 Jan 1
15 3196692 Characterization of cDNAs, mRNAs, and proteins related to human liver microsomal cytochrome P-450 (S)-mephenytoin 4'-hydroxylase. 1988 Sep 6 1
16 3032244 Cloning and sequence determination of a complementary DNA related to human liver microsomal cytochrome P-450 S-mephenytoin 4-hydroxylase. 1987 Feb 24 1
17 3442670 Genetic polymorphism of human cytochrome P-450 (S)-mephenytoin 4-hydroxylase. Studies with human autoantibodies suggest a functionally altered cytochrome P-450 isozyme as cause of the genetic deficiency. 1987 Dec 15 3
18 3598900 Hepatic metabolism of tolbutamide: characterization of the form of cytochrome P-450 involved in methyl hydroxylation and relationship to in vivo disposition. 1987 Jun 1
19 2874666 The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation. 1986 May 2
20 3096378 Mephenytoin-type polymorphism of drug oxidation: purification and characterization of a human liver cytochrome P-450 isozyme catalyzing microsomal mephenytoin hydroxylation. 1986 Dec 10 5
21 3709029 Polymorphic metabolism of mephenytoin in man: pharmacokinetic interaction with a co-regulated substrate, mephobarbital. 1986 Jun 1
22 4053486 Mephenytoin hydroxylation polymorphism: characterization of the enzymatic deficiency in liver microsomes of poor metabolizers phenotyped in vivo. 1985 Nov 2
23 6697650 Sparteine oxidation by the human liver: absence of inhibition by mephenytoin. 1984 Mar 1
24 1021219 Binding of anticonvulsant drugs to cytochrome P-450: correlation with evidence of induction of hepatic microsomal enzymes. 1976 Dec 1